Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
05:09

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

[Odanacatib (MK-0822)].

Yuichi Nagase1, Sakae Tanaka

  • 1Department of Orthopaedic Sugery, The University of Tokyo Hospital.

Clinical Calcium
|December 29, 2010
PubMed
Summary
This summary is machine-generated.

Bisphosphonates treat osteoporosis by reducing bone resorption but can cause side effects. Cathepsin K inhibitors offer a new approach to inhibit bone resorption without impacting bone formation, presenting a promising therapeutic target.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Treatment for Toe Deformities in Stiff-Person Syndrome: A Case Report.

JBJS case connector·2020
Same author

Evaluations of daily teriparatide using finite-element analysis over 12 months in rheumatoid arthritis patients.

Journal of bone and mineral metabolism·2020
Same author

The small compound, TD-198946, protects against intervertebral degeneration by enhancing glycosaminoglycan synthesis in nucleus pulposus cells.

Scientific reports·2020
Same author

Predictive factors of the 30-day mortality after surgery for spinal metastasis: Analysis of a nationwide database.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association·2020
Same author

In vivo length change of ligaments of normal knees during dynamic high flexion.

BMC musculoskeletal disorders·2020
Same author

Surgical margin for phosphaturic mesenchymal tumors in soft tissues: An analysis of the radiological histopathological correlation.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association·2020
Same journal

[The frontier of adipocyte biology, cold environment induces thermogenic genes via epigenomic switch.]

Clinical calcium·2019
Same journal

[Sequential treatment of osteoporosis with anti-sclerostin.]

Clinical calcium·2019
Same journal

[The sequential therapy of romosozumab followed by denosumab for osteoporosis.]

Clinical calcium·2019
Same journal

[Wnt signaling in myeloma.]

Clinical calcium·2019
Same journal

[Fate decision of hematopoietic stem cells by Wnt signaling.]

Clinical calcium·2019
Same journal

[Control of inflammatory bone destruction by targeting the Wnt signaling pathway.]

Clinical calcium·2019
See all related articles

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Context:

  • Bone homeostasis relies on a balance between osteoclasts (resorption) and osteoblasts (formation).
  • Osteoporosis treatment often involves bisphosphonates, which suppress bone resorption but may lead to adverse effects like osteonecrosis of the jaw and excessive suppression of bone turnover.
  • There is a need for novel osteoporosis therapies with improved safety and efficacy profiles.

Purpose:

  • To explore the therapeutic potential of Cathepsin K inhibitors as a novel treatment for osteoporosis.
  • To investigate the mechanism of Cathepsin K in bone resorption and its potential as a therapeutic target.
  • To compare the efficacy and safety of Cathepsin K inhibitors with existing bisphosphonate therapies.

Summary:

  • Cathepsin K is a protease specifically expressed in osteoclasts, crucial for bone collagen degradation.

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Tuina Intervention in Sodium Monoiodoacetate Injection-Induced Rat Model of Knee Osteoarthritis
06:14

Tuina Intervention in Sodium Monoiodoacetate Injection-Induced Rat Model of Knee Osteoarthritis

Published on: January 12, 2024

Related Experiment Videos

Last Updated: Jun 5, 2026

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
05:09

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Tuina Intervention in Sodium Monoiodoacetate Injection-Induced Rat Model of Knee Osteoarthritis
06:14

Tuina Intervention in Sodium Monoiodoacetate Injection-Induced Rat Model of Knee Osteoarthritis

Published on: January 12, 2024

  • Cathepsin K inhibitors function by inhibiting bone resorption through a novel mechanism.
  • Unlike bisphosphonates, Cathepsin K inhibitors have the potential to inhibit bone resorption without suppressing bone formation.

    • Impact:

    • Cathepsin K inhibitors represent a promising new therapeutic strategy for osteoporosis.
    • This approach may offer an alternative to bisphosphonates, potentially reducing side effects associated with excessive bone turnover suppression.
    • Further research into Cathepsin K inhibitors could lead to improved treatments for bone diseases.